REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $608,872 | -32.4% | 36,991 | -17.9% | 0.00% | 0.0% |
| Q2 2023 | $900,709 | +43.9% | 45,058 | +36.1% | 0.00% | 0.0% |
| Q1 2023 | $625,996 | -16.6% | 33,104 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $750,594 | -31.8% | 33,095 | -20.5% | 0.00% | 0.0% |
| Q3 2022 | $1,100,000 | +31.7% | 41,625 | +23.1% | 0.00% | 0.0% |
| Q2 2022 | $835,000 | -33.8% | 33,805 | -11.1% | 0.00% | 0.0% |
| Q1 2022 | $1,262,000 | +6.3% | 38,037 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $1,187,000 | -18.0% | 36,292 | +5.1% | 0.00% | 0.0% |
| Q3 2021 | $1,448,000 | -3.5% | 34,526 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $1,500,000 | +11.4% | 38,592 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $1,346,000 | -50.3% | 39,409 | -34.0% | 0.00% | 0.0% |
| Q4 2020 | $2,709,000 | -81.3% | 59,737 | -88.7% | 0.00% | -88.9% |
| Q3 2020 | $14,509,000 | -26.6% | 527,243 | -1.8% | 0.01% | -35.7% |
| Q2 2020 | $19,778,000 | +21.5% | 536,998 | +6.9% | 0.01% | 0.0% |
| Q1 2020 | $16,273,000 | -21.9% | 502,566 | -1.1% | 0.01% | -6.7% |
| Q4 2019 | $20,823,000 | +19.9% | 508,247 | +4.2% | 0.02% | 0.0% |
| Q3 2019 | $17,368,000 | -31.6% | 487,854 | -1.3% | 0.02% | -34.8% |
| Q2 2019 | $25,403,000 | -10.5% | 494,515 | -0.2% | 0.02% | -11.5% |
| Q1 2019 | $28,385,000 | +32.3% | 495,291 | -3.1% | 0.03% | +18.2% |
| Q4 2018 | $21,448,000 | -36.1% | 511,284 | +14.9% | 0.02% | -26.7% |
| Q3 2018 | $33,591,000 | +38.3% | 444,911 | +31.4% | 0.03% | +25.0% |
| Q2 2018 | $24,294,000 | +2563.8% | 338,578 | +1008.1% | 0.02% | +2300.0% |
| Q1 2018 | $912,000 | -1.9% | 30,555 | +9.4% | 0.00% | 0.0% |
| Q4 2017 | $930,000 | -18.6% | 27,937 | -19.4% | 0.00% | 0.0% |
| Q3 2017 | $1,142,000 | +105.0% | 34,664 | +22.8% | 0.00% | 0.0% |
| Q2 2017 | $557,000 | +45.1% | 28,229 | +41.6% | 0.00% | – |
| Q1 2017 | $384,000 | -37.7% | 19,934 | -39.9% | 0.00% | -100.0% |
| Q4 2016 | $616,000 | +576.9% | 33,187 | +191.4% | 0.00% | – |
| Q2 2016 | $91,000 | – | 11,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |